Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer's disease and cerebral amyloid angiopathy (Q48195821)

9 February 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer's disease and cerebral amyloid angiopathy (English)

1 reference

9 February 2018

0 references

Santpere G

1 reference

9 February 2018

Puig B

series ordinal

1 reference

9 February 2018

Ferrer I

series ordinal

1 reference

9 February 2018

language of work or name

English

0 references

publication date

19 April 2007

1 reference

9 February 2018

published in

Neuroscience

1 reference

9 February 2018

volume

146

1 reference

9 February 2018

issue

1 reference

9 February 2018

page(s)

1640-1651

1 reference

9 February 2018

Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Amyloid &#946;-Peptide [1-42]-Associated Free Radical-Induced Oxidative Stress And Neurodegeneration in Alzheimers Disease Brain: Mechanisms and Consequences

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3 proteins in the nervous system

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Role of 14-3-3 proteins in eukaryotic signaling and development

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Protective effect of D609 against amyloid-beta1-42-induced oxidative modification of neuronal proteins: redox proteomics study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

C-terminal binding: an expanded repertoire and function of 14-3-3 proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

The 14-3-3 proteins: gene, gene expression, and function

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Degradation of oxidized proteins by the 20S proteasome.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3 proteins in cell cycle regulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Unlocking the code of 14-3-3.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Neurodegenerative tauopathies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Involvement of oxidative stress in Alzheimer disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Tau function and dysfunction in neurons: its role in neurodegenerative disorders

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Tau protein as a differential biomarker of tauopathies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3 proteins--an update

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Differential functions of 14-3-3 isoforms in vertebrate development

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3 proteins: a historic overview

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3 proteins: regulators of numerous eukaryotic proteins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

14-3-3zeta is an effector of tau protein phosphorylation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Tau protein pathology in neurodegenerative diseases

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROSCIENCE.2007.03.013

Identifiers

DOI

10.1016/J.NEUROSCIENCE.2007.03.013

1 reference

9 February 2018

1 reference

9 February 2018